Assistant Professor, Medicine, University of Miami School of Medicine
Rheumatology
Dr. Dana P. Ascherman, MD
|
|
Give Review
Dana Ascherman is an expert in the field of Rheumatology. He attended Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification", "Fellow" and "Fellow (FACR)". Doctor Dana P. Ascherman, MD is a published doctor. He has 30 publications published. The most current publication "Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta ..."
Publications
- Detection of Rheumatoid Arthritis-Interstitial Lung Disease is Enhanced by Serum Biomarkers.
- Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
- Lupus vasculopathy: Diagnostic, pathogenetic and therapeutic considerations.
- Functional Redundancy of MyD88-Dependent Signaling Pathways in a Murine Model of Histidyl-Transfer RNA Synthetase-Induced Myositis.
- Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
- Identification of citrullinated heat shock protein 90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease.
- Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial.
- Animal models of inflammatory myopathy.
- Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis.
- Role of innate immunity in a model of histidyl-tRNA synthetase (Jo-1)-mediated myositis.
- Interstitial lung disease in rheumatoid arthritis.
- The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome.
- Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.
- Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.
- Animal models in myositis.
- Structural and thermodynamic approach to peptide immunogenicity.
- Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.
- The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses.
- Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis.
- Pulmonary complications of inflammatory myopathy.
- Prevention of rapid intracellular degradation of ODC by a carboxyl-terminal truncation.
- Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. A secreted lysosomal protease regulated by transformation.
- IS10 promotes adjacent deletions at low frequency.
- Vasculitic neuropathy--electrodiagnostic findings and association with malignancies.
- Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation.
- CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling.
- Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta ...
- Isolated Candida albicans Arthritis In a Non-Intravenous Drug-Abusing Patient With Acquired Immune Deficiency Syndrome.
- Systemic lupus erythematosus, pemphigus erythematosus, and thymoma in the same patient.
Schools
Stanford University School Of Medicine
Georgetown University Hospital
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow
- Fellow (FACR)
Education
-
Georgetown University Hospital -
Stanford University School of Medicine
Hospital
-
University of Miami Hospital -
Miami Veterans Affairs Healthcare System
Drug Facts
| NPI NUMBER | 1720050123 | |
| NPPES Provider LastName | ASCHERMAN | |
| NPPES Provider FirstName | DANA | |
| NPPES Provider ZIPCode | 331361002 | |
| NPPES Provider State | FL | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 229.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720050123 |
| Last Name Of The Provider | ASCHERMAN |
| First Name Of The Provider | DANA |
| View All |
Similar Doctors
|
|
Dr. Fotios Koumpouras, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan Manzi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antonio A. Achkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noah S. Bass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry W. Moreland, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Siamak Moghadam-Kia, MD |
|
|
Dr. Christine Peoples, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Burton H. Pollock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chian K. Kwoh, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kelly D. Krohn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy H. Kao, MD |